Search Results - "Lees, Charlie W."

Refine Results
  1. 1
  2. 2

    IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology by Jones, Gareth-Rhys, Lyons, Mathew, Plevris, Nikolas, Jenkinson, Philip W, Bisset, Cathy, Burgess, Christopher, Din, Shahida, Fulforth, James, Henderson, Paul, Ho, Gwo-Tzer, Kirkwood, Kathryn, Noble, Colin, Shand, Alan G, Wilson, David C, Arnott, Ian Dr, Lees, Charlie W

    Published in Gut (01-11-2019)
    “…IBD prevalence is estimated to be rising, but no detailed, recent UK data are available. The last reported prevalence estimate in the UK was 0.40% in 2003. We…”
    Get more information
    Journal Article
  3. 3
  4. 4

    The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing by Kennedy, Nicholas A, Walker, Alan W, Berry, Susan H, Duncan, Sylvia H, Farquarson, Freda M, Louis, Petra, Thomson, John M, Satsangi, Jack, Flint, Harry J, Parkhill, Julian, Lees, Charlie W, Hold, Georgina L

    Published in PloS one (24-02-2014)
    “…Determining bacterial community structure in fecal samples through DNA sequencing is an important facet of intestinal health research. The impact of different…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program by Chiorean, Michael, Daperno, Marco, Lees, Charlie W., Bonfanti, Gianluca, Soudis, Dimitrios, Modesto, Irene, Deuring, J. Jasper, Edwards, Roger A.

    Published in Advances in therapy (01-10-2023)
    “…Introduction Tofacitinib is an oral small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). This post hoc analysis assessed whether…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities by Plevris, Nikolas, Lees, Charlie W.

    Published in Gastroenterology (New York, N.Y. 1943) (01-04-2022)
    “…Inflammatory bowel disease is a progressive and debilitating condition. Early and effective treatment using a treat-to-target approach is key to improving…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis by Gros, Beatriz, Ross, Hannah, Nwabueze, Maureen, Constantine-Cooke, Nathan, Derikx, Lauranne A A P, Lyons, Mathew, O'Hare, Claire, Noble, Colin, Arnott, Ian D, Jones, Gareth-Rhys, Lees, Charlie W, Plevris, Nikolas

    Published in Therapeutic advances in gastroenterology (01-01-2024)
    “…Long-term vedolizumab (VDZ) outcomes in real-world cohorts have been largely limited to 1-year follow-up, with few bio-naïve patients or objective markers of…”
    Get full text
    Journal Article
  14. 14

    Bilateral lower limb weakness in acute severe ulcerative colitis by Lynch, Ruairi W, MB, Soane, Timothy, PhD, Gibson, Rod, MB, Pal, Suvankar, MD, Lees, Charlie W, Dr

    Published in The Lancet (British edition) (02-07-2016)
    “…An obese 49-year-old man with no medical history of note presented in August, 2014, with a 5-week history of bloody diarrhoea, anorexia, and unintentional…”
    Get full text
    Journal Article
  15. 15

    Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studies by Lees, Charlie W., Deuring, J. Jasper, Chiorean, Michael, Daperno, Marco, Bonfanti, Gianluca, Germino, Rebecca, Brown, Pritha Bhadra, Modesto, Irene, Edwards, Roger A.

    Published in Therapeutic advances in gastroenterology (01-11-2021)
    “…Introduction: Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). Outcome prediction based on early…”
    Get full text
    Journal Article
  16. 16

    Environmental stimuli and gut inflammation via dysbiosis in mouse and man by Lees, Charlie W.

    “…A new study sheds further light on the interplay between environmental stimuli, the gut microbiota and intestinal inflammation. Identification of modifiable…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease by Kennedy, Nicholas A., Jones, Gareth-Rhys, Plevris, Nikolas, Patenden, Rebecca, Arnott, Ian D., Lees, Charlie W.

    Published in Clinical gastroenterology and hepatology (01-10-2019)
    “…Mucosal healing is associated with improved outcomes in patients with Crohn’s disease (CD), but assessment typically requires ileocolonoscopy. Calprotectin can…”
    Get full text
    Journal Article